Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06453135
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-13
First Post:
2024-06-05
Brief Title:
Eculizumab for Prevention of Antibody-Mediated Rejection in ABO-Incompatible Living Donor Kidney Transplantation
Sponsor:
Tao Lin
Organization:
West China Hospital
Organization Data
Organization:
West China Hospital
Class:
OTHER
Study ID:
WestChina-ECU-KT
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Tao Lin
Lead Sponsor Class:
OTHER
Responsible Party:
Tao Lin
Responsible Party Title:
Principal Investigator PI
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
West China Hospital
Old Name:
None
Old Organization:
None